Autopsy report · NCT00768742

Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study

“study revised and reinitiated under another protocol”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Gynesonics

Sponsor type

Industry

Conditions

Leiomyoma; Uterine Fibroids; Menorrhagia

Interventions

VizAblate Intrauterine Ultrasound-Guided RF Ablation

Participants

0

Sites

3

Countries

Canada

Trials that died the same way

• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (82% match in meaning)
• Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
  “Study was redeveloped into a new protocol” (79% match in meaning)
• Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury
  “revised and combined with another protocol” (79% match in meaning)
• Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
  “On 05/08/12, team working on revising protocol and re-open study under version 2.0” (75% match in meaning)
• Study of Stored Tumor Samples in Young Patients With Brain Tumors
  “New Protocol that replaces the current study” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.